Cassa E Equivalenti Cambiamento Data
AbbVie USD 10.77B 4.2B 2026-09
Acadia Pharmaceuticals USD 976.45M 19.97M 2026-09
ALKERMES USD 631.31M 119.78M 2026-09
Amgen USD 13.19B 799M 2026-09
Biogen USD 1.3B 18.9M 2026-09
BioMarin Pharmaceutical USD 736.01M 138M 2026-09
Bristol-Myers Squibb USD 9.57B 852M 2026-09
Coherus Biosciences USD 82.92M 32.32M 2026-06
Eli Lilly USD 4.89B 4.07B 2026-09
Gilead Sciences USD 3.18B 4.45B 2026-06
Heron Therapeutics USD 11.6M 9.13M 2026-09
Ionis Pharmaceuticals USD 296.3M 53.76M 2026-09
J&J USD 16.91B 3.51B 2026-09
Malin Corporation EUR 62.1M 26.4M 2024-12
Merck USD 9.55B 2.7B 2026-09
Minerva Neurosciences USD 82.3M 70.02M 2025-12
Nektar Therapeutics USD 149.58M 134.46M 2026-03
Neurocrine Biosciences USD 641.5M 309.1M 2026-09
Otsuka Holdings JPY 472.49B 2.94B 2026-09
Pfizer USD 1.82B 848M 2026-09
Regeneron Pharmaceuticals USD 3.66B 1.2B 2026-09
Vertex Pharmaceuticals USD 6.3B 1.55B 2026-09